Partnership Expansion Strategic collaboration potential with Sarah Cannon Research Institute announced Aug 2025 to expand access to cutting-edge cancer trials in Mid-Missouri, presenting a clear channel for co-marketing, trial recruitment services, and joint patient programs.

Integrated Care Model On-site chemotherapy, radiation, pharmacy, and lab enable streamlined patient experiences and quicker treatment initiation, offering a value proposition for hospitals or clinics seeking referable care pathways and bundled services.

Mid-Missouri Focus Regional focus in Mid-Missouri with a veteran, patient-centered approach positions the practice as a preferred local partner for referrals, community outreach, and payer negotiations within a defined market.

Growth Indicators Revenue in the $10-25M range and a workforce of up to 200 suggest a scalable platform with potential for tele-oncology expansions, regional partnerships, and joint ventures with larger cancer networks.

Technology & Outreach Tech stack includes CDN and analytics tools (Fastly, Cloudflare, Google Tag Manager, Yoast SEO) and marketing automation (Mailchimp), indicating opportunities to offer digital marketing services, patient acquisition programs, and data-driven outreach enhancements.